Desvenlafaxine (or PRISTIQ®) is mainly prescribed to treat major depressive disorder.
Class: Serotonin-norepinephrine Reuptake Inhibitor (SNRI)
FDA Approval: 2007
Dosage Forms: 25 mg, 50 mg, 100 mg
Biological Half-life: 11 hours
Side Effects: Dizziness, blurred vision, dry mouth, headache, insomnia, nausea, fatigue, diarrhea, constipation, hyperhidrosis, decreased appetite, elevated cholesterol, hot flush, irritability, abnormal dreams, skin rash, increased suicide risk
Routes of Administration: Oral
Pregnancy Category: C (US)